146 related articles for article (PubMed ID: 8408036)
1. Thrombospondin 1 is a tight-binding competitive inhibitor of neutrophil cathepsin G. Determination of the kinetic mechanism of inhibition and localization of cathepsin G binding to the thrombospondin 1 type 3 repeats.
Hogg PJ; Owensby DA; Chesterman CN
J Biol Chem; 1993 Oct; 268(29):21811-8. PubMed ID: 8408036
[TBL] [Abstract][Full Text] [Related]
2. Identification of possible inhibitory reactive centers in thrombospondin 1 that may bind cathepsin G and neutrophil elastase.
Hogg PJ; Jiménez BM; Chesterman CN
Biochemistry; 1994 May; 33(21):6531-7. PubMed ID: 8204588
[TBL] [Abstract][Full Text] [Related]
3. Thrombospondin is a tight-binding competitive inhibitor of neutrophil elastase.
Hogg PJ; Owensby DA; Mosher DF; Misenheimer TM; Chesterman CN
J Biol Chem; 1993 Apr; 268(10):7139-46. PubMed ID: 8463250
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous determination of Pseudomonas aeruginosa elastase, human leukocyte elastase and cathepsin G activities by micellar electrokinetic chromatography.
Viglio S; Luisetti M; Zanaboni G; Döring G; Worlitzsch D; Cetta G; Iadarola P
J Chromatogr A; 1999 Jun; 846(1-2):125-34. PubMed ID: 10420604
[TBL] [Abstract][Full Text] [Related]
5. Human neutrophil elastase proteolytically activates the platelet integrin alphaIIbbeta3 through cleavage of the carboxyl terminus of the alphaIIb subunit heavy chain. Involvement in the potentiation of platelet aggregation.
Si-Tahar M; Pidard D; Balloy V; Moniatte M; Kieffer N; Van Dorsselaer A; Chignard M
J Biol Chem; 1997 Apr; 272(17):11636-47. PubMed ID: 9111081
[TBL] [Abstract][Full Text] [Related]
6. Interference of recombinant eglin C, a proteinase inhibitor extracted from leeches, with neutrophil-mediated platelet activation.
Renesto P; Ferrer-Lopez P; Chignard M
Lab Invest; 1990 Apr; 62(4):409-16. PubMed ID: 2159081
[TBL] [Abstract][Full Text] [Related]
7. Nonchromogenic hydrolysis of elastase and cathepsin G p-nitroanilide substrates by Pseudomonas aeruginosa elastase.
Pelletier A; Dimicoli JL; Boudier C; Bieth JG
Am J Respir Cell Mol Biol; 1989 Jul; 1(1):37-9. PubMed ID: 2516450
[TBL] [Abstract][Full Text] [Related]
8. Cathepsin G in human mononuclear phagocytes: comparisons between monocytes and U937 monocyte-like cells.
Senior RM; Campbell EJ
J Immunol; 1984 May; 132(5):2547-51. PubMed ID: 6562154
[TBL] [Abstract][Full Text] [Related]
9. Specificity of human cathepsin G.
Polanowska J; Krokoszynska I; Czapinska H; Watorek W; Dadlez M; Otlewski J
Biochim Biophys Acta; 1998 Jul; 1386(1):189-98. PubMed ID: 9675278
[TBL] [Abstract][Full Text] [Related]
10. Thrombospondin 1 as an enzyme inhibitor.
Hogg PJ
Thromb Haemost; 1994 Dec; 72(6):787-92. PubMed ID: 7740442
[No Abstract] [Full Text] [Related]
11. Inhibition of the serine proteases leukocyte elastase, pancreatic elastase, cathepsin G, and chymotrypsin by peptide boronic acids.
Kettner CA; Shenvi AB
J Biol Chem; 1984 Dec; 259(24):15106-14. PubMed ID: 6392293
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of peptidyl fluoromethyl ketones and peptidyl alpha-keto esters as inhibitors of porcine pancreatic elastase, human neutrophil elastase, and rat and human neutrophil cathepsin G.
Peet NP; Burkhart JP; Angelastro MR; Giroux EL; Mehdi S; Bey P; Kolb M; Neises B; Schirlin D
J Med Chem; 1990 Jan; 33(1):394-407. PubMed ID: 2296031
[TBL] [Abstract][Full Text] [Related]
13. New, sensitive fluorogenic substrates for human cathepsin G based on the sequence of serpin-reactive site loops.
Réhault S; Brillard-Bourdet M; Juliano MA; Juliano L; Gauthier F; Moreau T
J Biol Chem; 1999 May; 274(20):13810-7. PubMed ID: 10318785
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil elastase potentiates cathepsin G-induced platelet activation.
Selak MA
Thromb Haemost; 1992 Nov; 68(5):570-6. PubMed ID: 1333649
[TBL] [Abstract][Full Text] [Related]
15. Interaction of heparin cofactor II with neutrophil elastase and cathepsin G.
Pratt CW; Tobin RB; Church FC
J Biol Chem; 1990 Apr; 265(11):6092-7. PubMed ID: 2318847
[TBL] [Abstract][Full Text] [Related]
16. Proteolysis of the human platelet and endothelial cell thrombin receptor by neutrophil-derived cathepsin G.
Molino M; Blanchard N; Belmonte E; Tarver AP; Abrams C; Hoxie JA; Cerletti C; Brass LF
J Biol Chem; 1995 May; 270(19):11168-75. PubMed ID: 7744748
[TBL] [Abstract][Full Text] [Related]
17. The 1.8 A crystal structure of human cathepsin G in complex with Suc-Val-Pro-PheP-(OPh)2: a Janus-faced proteinase with two opposite specificities.
Hof P; Mayr I; Huber R; Korzus E; Potempa J; Travis J; Powers JC; Bode W
EMBO J; 1996 Oct; 15(20):5481-91. PubMed ID: 8896442
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II generation at the cell surface of activated neutrophils: novel cathepsin G-mediated catalytic activity that is resistant to inhibition.
Owen CA; Campbell EJ
J Immunol; 1998 Feb; 160(3):1436-43. PubMed ID: 9570564
[TBL] [Abstract][Full Text] [Related]
19. The serpin MNEI inhibits elastase-like and chymotrypsin-like serine proteases through efficient reactions at two active sites.
Cooley J; Takayama TK; Shapiro SD; Schechter NM; Remold-O'Donnell E
Biochemistry; 2001 Dec; 40(51):15762-70. PubMed ID: 11747453
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of neutrophil cathepsin G by oxidized mucus proteinase inhibitor. Effect of heparin.
Boudier C; Cadène M; Bieth JG
Biochemistry; 1999 Jun; 38(26):8451-7. PubMed ID: 10387091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
